Index by author

April 01, 2025; Volume 92,Issue 4

  1. Cheng, M. Jennifer

    1. Psychedelics, spirituality, and existential distress in patients at the end of life
      Nicole Cornish, PharmD, Tara Coles, MD, M. Jennifer Cheng, MD, Claudia Ruiz Sotomayor, MD, DBe, Aaron Wolfgang, MD and Christopher Spevak, MD, MPH, JD
      Cleveland Clinic Journal of Medicine April 2025, 92 (4) 248-254; DOI: https://doi.org/10.3949/ccjm.92a.24100

      The authors explore the role of psychedelics in addressing patients’ spiritual and existential suffering at the end of life from a medical, ethical, and legal perspective.

  2. Cohn, Steven L.

    1. 2024 ACC/AHA guideline on perioperative cardiovascular management before noncardiac surgery: What’s new?
      CME article
      Steven L. Cohn, MD
      Cleveland Clinic Journal of Medicine April 2025, 92 (4) 213-219; DOI: https://doi.org/10.3949/ccjm.92a.24125

      The author highlights key changes and recommendations of the new guideline, how they differ from previous and other society guidelines, and ongoing challenges and unresolved issues in perioperative care.

  3. Coles, Tara

    1. Psychedelics, spirituality, and existential distress in patients at the end of life
      Nicole Cornish, PharmD, Tara Coles, MD, M. Jennifer Cheng, MD, Claudia Ruiz Sotomayor, MD, DBe, Aaron Wolfgang, MD and Christopher Spevak, MD, MPH, JD
      Cleveland Clinic Journal of Medicine April 2025, 92 (4) 248-254; DOI: https://doi.org/10.3949/ccjm.92a.24100

      The authors explore the role of psychedelics in addressing patients’ spiritual and existential suffering at the end of life from a medical, ethical, and legal perspective.

  4. Cornish, Nicole

    1. Psychedelics, spirituality, and existential distress in patients at the end of life
      Nicole Cornish, PharmD, Tara Coles, MD, M. Jennifer Cheng, MD, Claudia Ruiz Sotomayor, MD, DBe, Aaron Wolfgang, MD and Christopher Spevak, MD, MPH, JD
      Cleveland Clinic Journal of Medicine April 2025, 92 (4) 248-254; DOI: https://doi.org/10.3949/ccjm.92a.24100

      The authors explore the role of psychedelics in addressing patients’ spiritual and existential suffering at the end of life from a medical, ethical, and legal perspective.

Back to top

In this issue